|
Capecitabine 825 mg/m2 twice daily on weekdays Clinical Trials
1 actively recruiting trial
Pipeline
Phase 3: 1
Top Sponsors
- Vejle Hospital1
Indications
- Cancer of Rectum1
- Cancer1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.